Global Preliminary Screening Tests Market Key Players Competitive Survey Report 2023

Report ID: ARS11107 | Category: Healthcare | Pages: 111 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3650.00 Multi User-$6200.00

Report Description
View Table of Contents

Report Summary

The global Preliminary Screening Tests market size in 2022 is 2843.2 million US dollars, and it is expected to be 8054.8 million US dollars by 2029, with a compound annual growth rate of 16.04% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Preliminary Screening Tests market include Akers Biosciences, Inc. (U.S.), Abbott (U.S.), BD (U.S.), Bio-rad Laboratories, Inc. (U.S.), and Cepheid (U.S.). The share of the top 3 players in the Preliminary Screening Tests market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Preliminary Screening Tests market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Over-the-Counter (OTC) Rapid Test Product accounted for XX% of Preliminary Screening Tests market in 2022. Professional Rapid Test Product share of XX%.
Hospital and Clinic accounted for XX% of the Preliminary Screening Tests market in 2022. Diagnostic Laboratory accounts for XX%.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Preliminary Screening Tests market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.

The report analyzes the key trends in each segment of the global Preliminary Screening Tests market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.

Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Preliminary Screening Tests market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Preliminary Screening Tests market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Preliminary Screening Tests industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.

Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapters 2-4: Segmented the global Preliminary Screening Tests market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Preliminary Screening Tests market type, application and country market segmentation data.
Chapter 10: Analysis of the competitive environment of Preliminary Screening Tests market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapter 11: Analyzes the main companies in the Preliminary Screening Tests industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed Preliminary Screening Tests market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Akers Biosciences, Inc. (U.S.)
Abbott (U.S.)
BD (U.S.)
Bio-rad Laboratories, Inc. (U.S.)
Cepheid (U.S.)
Hologic Inc. (U.S.)
Meridian Bioscience, Inc. (U.S.)
OraSure Technologies, Inc. (U.S.)
Quidel Corporation (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
BUREAU VERITAS (U.S.)
Eurofins Scientific (Luxembourg)
Siemens Healthcare Private Limited (Germany)
Luminex Corporation (U.S.)
PerkinElmer Inc. (U.S.)
QIAGEN (Germany)
Mesa Biotech (U.S.)
Illumina, Inc (U.S.)

Types list
Over-the-Counter (OTC) Rapid Test Product
Professional Rapid Test Product

Application list
Hospital and Clinic
Diagnostic Laboratory
Home Care
Others

Table of Content

1 Preliminary Screening Tests Market Introduction and Overview
1.1 Preliminary Screening Tests Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Preliminary Screening Tests Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Preliminary Screening Tests Revenue and Market Share by Type
3 Global Preliminary Screening Tests Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Preliminary Screening Tests Revenue Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Preliminary Screening Tests Market Size (2018-2023)
4.2 Preliminary Screening Tests Growth Trends Analysis by Regions
4.2.1 Preliminary Screening Tests Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Preliminary Screening Tests Historic Revenue Market Size by Regions (2018-2023)
4.2.3 North America Preliminary Screening Tests Market Size (2018-2023)
4.2.4 Europe Preliminary Screening Tests Market Size (2018-2023)
4.2.5 Asia-Pacific Preliminary Screening Tests Market Size (2018-2023)
4.2.6 Latin America Preliminary Screening Tests Market Size (2018-2023)
4.2.7 Middle East & Africa Preliminary Screening Tests Market Size (2018-2023)
5 North America
5.1 North America Preliminary Screening Tests Revenue by Countries
5.1.1 North America Preliminary Screening Tests Revenue by Countries (2018-2023)
5.2 North America Preliminary Screening Tests Revenue by Types
5.3 North America Preliminary Screening Tests Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Preliminary Screening Tests Revenue by Countries
6.1.1 Asia Pacific Preliminary Screening Tests Revenue by Countries (2018-2023)
6.2 Asia Pacific Preliminary Screening Tests Revenue by Types
6.3 Asia Pacific Preliminary Screening Tests Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Preliminary Screening Tests Revenue by Countries
7.1.1 Europe Preliminary Screening Tests Revenue by Countries (2018-2023)
7.2 Europe Preliminary Screening Tests Revenue by Types
7.3 Europe Preliminary Screening Tests Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Preliminary Screening Tests Revenue by Countries
8.1.1 Latin America Preliminary Screening Tests Revenue by Countries (2018-2023)
8.2 Latin America Preliminary Screening Tests Revenue by Types
8.3 Latin America Preliminary Screening Tests Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Preliminary Screening Tests Revenue by Countries
9.1.1 Middle East & Africa Preliminary Screening Tests Revenue by Countries (2018-2023)
9.2 Middle East & Africa Preliminary Screening Tests Revenue by Types
9.3 Middle East & Africa Preliminary Screening Tests Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Preliminary Screening Tests Market Competition, by Players
10.1 Global Preliminary Screening Tests Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Preliminary Screening Tests Players Market Share in 2022
10.2.2 Top 6 Preliminary Screening Tests Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Preliminary Screening Tests Players Head Office, Business Provided
10.4 Preliminary Screening Tests Mergers & Acquisitions
10.5 Preliminary Screening Tests New Entrants and Expansion Plans
11 Players Profiles11.1 Akers Biosciences, Inc. (U.S.)
11.1.1 Akers Biosciences, Inc. (U.S.) Company Profile
11.1.2 Preliminary Screening Tests Product Overview
11.1.3 Akers Biosciences, Inc. (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.1.4 Akers Biosciences, Inc. (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 Abbott (U.S.)
11.2.1 Abbott (U.S.) Company Profile
11.2.2 Preliminary Screening Tests Product Overview
11.2.3 Abbott (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.2.4 Abbott (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 BD (U.S.)
11.3.1 BD (U.S.) Company Profile
11.3.2 Preliminary Screening Tests Product Overview
11.3.3 BD (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.3.4 BD (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Bio-rad Laboratories, Inc. (U.S.)
11.4.1 Bio-rad Laboratories, Inc. (U.S.) Company Profile
11.4.2 Preliminary Screening Tests Product Overview
11.4.3 Bio-rad Laboratories, Inc. (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.4.4 Bio-rad Laboratories, Inc. (U.S.) Business Overview
11.4.5 Recent Developments and Plans
11.5 Cepheid (U.S.)
11.5.1 Cepheid (U.S.) Company Profile
11.5.2 Preliminary Screening Tests Product Overview
11.5.3 Cepheid (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.5.4 Cepheid (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 Hologic Inc. (U.S.)
11.6.1 Hologic Inc. (U.S.) Company Profile
11.6.2 Preliminary Screening Tests Product Overview
11.6.3 Hologic Inc. (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.6.4 Hologic Inc. (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Meridian Bioscience, Inc. (U.S.)
11.7.1 Meridian Bioscience, Inc. (U.S.) Company Profile
11.7.2 Preliminary Screening Tests Product Overview
11.7.3 Meridian Bioscience, Inc. (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.7.4 Meridian Bioscience, Inc. (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 OraSure Technologies, Inc. (U.S.)
11.8.1 OraSure Technologies, Inc. (U.S.) Company Profile
11.8.2 Preliminary Screening Tests Product Overview
11.8.3 OraSure Technologies, Inc. (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.8.4 OraSure Technologies, Inc. (U.S.) Business Overview
11.8.5 Recent Developments and Plans
11.9 Quidel Corporation (U.S.)
11.9.1 Quidel Corporation (U.S.) Company Profile
11.9.2 Preliminary Screening Tests Product Overview
11.9.3 Quidel Corporation (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.9.4 Quidel Corporation (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 F. Hoffmann-La Roche Ltd (Switzerland)
11.10.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
11.10.2 Preliminary Screening Tests Product Overview
11.10.3 F. Hoffmann-La Roche Ltd (Switzerland) Preliminary Screening Tests Market Performance (2018-2023)
11.10.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
11.10.5 Recent Developments and Plans
11.11 BUREAU VERITAS (U.S.)
11.11.1 BUREAU VERITAS (U.S.) Company Profile
11.11.2 Preliminary Screening Tests Product Overview
11.11.3 BUREAU VERITAS (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.11.4 BUREAU VERITAS (U.S.) Business Overview
11.11.5 Recent Developments and Plans
11.12 Eurofins Scientific (Luxembourg)
11.12.1 Eurofins Scientific (Luxembourg) Company Profile
11.12.2 Preliminary Screening Tests Product Overview
11.12.3 Eurofins Scientific (Luxembourg) Preliminary Screening Tests Market Performance (2018-2023)
11.12.4 Eurofins Scientific (Luxembourg) Business Overview
11.12.5 Recent Developments and Plans
11.13 Siemens Healthcare Private Limited (Germany)
11.13.1 Siemens Healthcare Private Limited (Germany) Company Profile
11.13.2 Preliminary Screening Tests Product Overview
11.13.3 Siemens Healthcare Private Limited (Germany) Preliminary Screening Tests Market Performance (2018-2023)
11.13.4 Siemens Healthcare Private Limited (Germany) Business Overview
11.13.5 Recent Developments and Plans
11.14 Luminex Corporation (U.S.)
11.14.1 Luminex Corporation (U.S.) Company Profile
11.14.2 Preliminary Screening Tests Product Overview
11.14.3 Luminex Corporation (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.14.4 Luminex Corporation (U.S.) Business Overview
11.14.5 Recent Developments and Plans
11.15 PerkinElmer Inc. (U.S.)
11.15.1 PerkinElmer Inc. (U.S.) Company Profile
11.15.2 Preliminary Screening Tests Product Overview
11.15.3 PerkinElmer Inc. (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.15.4 PerkinElmer Inc. (U.S.) Business Overview
11.15.5 Recent Developments and Plans
11.16 QIAGEN (Germany)
11.16.1 QIAGEN (Germany) Company Profile
11.16.2 Preliminary Screening Tests Product Overview
11.16.3 QIAGEN (Germany) Preliminary Screening Tests Market Performance (2018-2023)
11.16.4 QIAGEN (Germany) Business Overview
11.16.5 Recent Developments and Plans
11.17 Mesa Biotech (U.S.)
11.17.1 Mesa Biotech (U.S.) Company Profile
11.17.2 Preliminary Screening Tests Product Overview
11.17.3 Mesa Biotech (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.17.4 Mesa Biotech (U.S.) Business Overview
11.17.5 Recent Developments and Plans
11.18 Illumina, Inc (U.S.)
11.18.1 Illumina, Inc (U.S.) Company Profile
11.18.2 Preliminary Screening Tests Product Overview
11.18.3 Illumina, Inc (U.S.) Preliminary Screening Tests Market Performance (2018-2023)
11.18.4 Illumina, Inc (U.S.) Business Overview
11.18.5 Recent Developments and Plans
12 Global Preliminary Screening Tests Forecast Market Analysis by Type
12.1 Global Preliminary Screening Tests Revenue Market Forecast by Type (2023-2029)
13 Global Preliminary Screening Tests Forecast Market Analysis by Application
13.1 Preliminary Screening Tests Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Preliminary Screening Tests Forecast Market Size (2023-2029)
14.2 Preliminary Screening Tests Growth Trends Forecast Analysis by Regions
14.2.1 Preliminary Screening Tests Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Preliminary Screening Tests Forecast Market Size (2023-2029)
14.2.3 Europe Preliminary Screening Tests Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Preliminary Screening Tests Forecast Market Size (2023-2029)
14.2.5 Latin America Preliminary Screening Tests Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Preliminary Screening Tests Forecast Market Size (2023-2029)
15 Preliminary Screening Tests Industry Dynamic Analysis
15.1 Preliminary Screening Tests Market Trends Analysis
15.2 Preliminary Screening Tests Market Drivers Analysis
15.3 Preliminary Screening Tests Market Challenges Analysis
15.4 Preliminary Screening Tests Market Restraints Analysis

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Preliminary Screening Tests Market Key Players Competitive Survey Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?